⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22284776 | 0.79 | — | — | |
| SCHEMBL29405140 | 0.75 | — | — | |
| SCHEMBL70036 | 0.75 | — | — | |
| 2,4-Dichlorophenol SCHEMBL30084868 | 0.72 | — | — | |
| 2,4-Dichlorophenol SCHEMBL30396784 | 0.72 | — | — | |
| SCHEMBL25434699 | 0.72 | HSD17B10 (0.62) | — | |
| SCHEMBL10793095 | 0.72 | — | — | |
| SCHEMBL6242615 | 0.72 | HSD17B10 (0.62) | — | |
| 2,4-Dichlorophenol SCHEMBL77936 | 0.72 | — | — | |
| SCHEMBL31093991 | 0.72 | HSD17B10 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11850230-B2 | Composition for preventing or treating TNF-related diseases, containing novel derivative as active ingredient, and method for inhibiting TNF activity by using same | ILAB (KR) | 2023-12-26 | — | — | US | disclosed |
| US-20230099574-A1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING NOVEL DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2023-03-30 | — | — | US | disclosed |
| EP-3699174-A1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING NOVEL DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2020-08-26 | — | — | EP | disclosed |
| US-20200246304-A1 | Composition For Preventing Or Treating TNF-Related Diseases, Containing Novel Derivative As Active Ingredient, And Method For Inhibiting TNF Activity By Using Same | ILAB (KR) | 2020-08-06 | — | — | US | disclosed |